Recurrent and Refractory Solid Tumors
1 clinical trials · Condition
◉ Watch Recurrent and Refractory Solid Tumors
| Record | Firm | Date |
|---|---|---|
| Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric Solid Tumors, Including Central Nervous System Tumors (NCT03245151) | Eisai Inc. | 2017-11-16 |
Track Recurrent and Refractory Solid Tumors automatically
Every clearance here is in the API, with alerts when new ones post.